Black Friday saleUp to 70% OFF
Alector, Inc.Alector, Inc.Alector, Inc.

Alector, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ALEC chart


Full chart

ALEC upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪387.81 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.71 USD
Net income (FY)
‪−130.39 M‬ USD
Revenue (FY)
‪97.06 M‬ USD
Shares float
‪75.34 M‬
Beta (1Y)
3.06

Employees


Employees (FY)
244
Change (1Y)
−29 −10.62%
Revenue / Employee (1Y)
‪397.80 K‬ USD
Net income / Employee (1Y)
‪−534.39 K‬ USD

About Alector, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Arnon Rosenthal
Website
alector.com
Headquarters
South San Francisco
Founded
2013
FIGI
BBG00N0PL198
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ALEC news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALEC is 2.57 USD — it has decreased by −34.47% in the past 24 hours. Watch Alector, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alector, Inc. stocks are traded under the ticker ALEC.
ALEC stock has fallen by −29.86% compared to the previous week, the month change is a −44.55% fall, over the last year Alector, Inc. has showed a −47.87% decrease.
We've gathered analysts' opinions on Alector, Inc. future price: according to them, ALEC price has a max estimate of 15.00 USD and a min estimate of 3.00 USD. Watch ALEC chart and read a more detailed Alector, Inc. stock forecast: see what analysts think of Alector, Inc. and suggest that you do with its stocks.
ALEC reached its all-time high on Jul 2, 2021 with the price of 43.32 USD, and its all-time low was 3.49 USD and was reached on Nov 21, 2024. View more price dynamics on ALEC chart.
See other stocks reaching their highest and lowest prices.
ALEC stock is 67.09% volatile and has beta coefficient of 3.06. Track Alector, Inc. stock price on the chart and check out the list of the most volatile stocks — is Alector, Inc. there?
Today Alector, Inc. has the market capitalization of ‪387.81 M‬, it has decreased by −7.50% over the last week.
Yes, you can track Alector, Inc. financials in yearly and quarterly reports right on TradingView.
Alector, Inc. is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
ALEC earnings for the last quarter are −0.43 USD per share, whereas the estimation was −0.53 USD resulting in a 19.48% surprise. The estimated earnings for the next quarter are −0.62 USD per share. See more details about Alector, Inc. earnings.
Alector, Inc. revenue for the last quarter amounts to ‪15.34 M‬ USD, despite the estimated figure of ‪15.70 M‬ USD. In the next quarter, revenue is expected to reach ‪16.63 M‬ USD.
ALEC net income for the last quarter is ‪−42.22 M‬ USD, while the quarter before that showed ‪−38.68 M‬ USD of net income which accounts for −9.16% change. Track more Alector, Inc. financial stats to get the full picture.
No, ALEC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 27, 2024, the company has 244.00 employees. See our rating of the largest employees — is Alector, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alector, Inc. EBITDA is ‪−176.18 M‬ USD, and current EBITDA margin is −147.22%. See more stats in Alector, Inc. financial statements.
Like other stocks, ALEC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alector, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Alector, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Alector, Inc. stock shows the sell signal. See more of Alector, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.